Advanced Micro Devices
AMD
ASML Holding
ASML
Meta Platforms
META
Cisco
CSCO
Taiwan Semiconductor
TSM
US Stock MarketDetailed Quotes
PLRX Pliant Therapeutics
- 13.560
- -0.470-3.35%
Close Dec 27 16:00 ET
- 13.560
- 0.0000.00%
Post 16:01 ET
825.18MMarket Cap-4.05P/E (TTM)
14.230High13.480Low340.46KVolume13.980Open14.030Pre Close4.65MTurnover0.73%Turnover RatioLossP/E (Static)60.85MShares19.62052wk High2.39P/B634.63MFloat Cap10.22052wk Low--Dividend TTM46.80MShs Float43.920Historical High--Div YieldTTM5.35%Amplitude3.965Historical Low13.653Avg Price1Lot Size
Pliant Therapeutics Key Stats
EPS
According to the latest financial report of Pliant Therapeutics, the latest earnings per share (TTM) for the company is -0.95. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Pliant Therapeutics's free cash flow? The latest report shows it as -33.17M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Pliant Therapeutics shows that the company's current ratio is 10.26, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Pliant Therapeutics, the quick ratio is 10.18, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Pliant Therapeutics? The latest ROE figure is -15.64%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Pliant Therapeutics, the total asset return on investment (ROA) is -12.43%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Pliant Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Pliant Therapeutics, the net profit margin is -16.61K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.